主持代表性项目：

1. 益气养阴生脉方干预BCAT介导的铁死亡抑制心肌肥厚治疗慢性心衰的作用机制研究，国家自然科学基金面上项目，2026.1-2029.12，82574980，50万，负责人。

2. 益气活血方抑制KMO介导的线粒体动力学失衡改善缺血性心衰气虚血瘀证的作用机制研究，国家自然科学基金面上项目，2023.1-2026.12，82274231，52万，负责人。

3. 基于脂肪组织-心肌crosstalk探讨omentin改善心功能的作用机制及生脉制剂与活性成分的调节作用，国家自然科学基金面上项目，2020.1-2023.12，81973506，55万元，负责人。

代表性文章：

1. Yangyang Lin¹, Shuaishuai Gong¹, Qiong Lai¹, Pingping Lin, Minhui Sun, Boyang Yu, Junping Kou*, Lan Gao*, Fang Li*. Astragaloside II alleviates cardiac hypertrophy by targeting ACY1: a novel mechanism via the β-catenin/TCF4/UCHL1 axis. British Journal of Pharmacology, 2026. DOI: 10.1111/bph.70416

2. Yan Yan¹, Shuaishuai Gong¹, Minhui Sun¹, Zhekai Huang¹, Lan Gao, Xinxin Li, Boyang Yu, Junping Kou*,Chenhui Du*, Fang Li*. 6’’’-feruloylspinosin ameliorates pressure overload-induced heart failure with comorbid insomnia through the activation of RORα. British Journal of Pharmacology, 2026, 183: 1557-1577.

3. Shuaishuai Gong¹, Hong Chen¹, Shuhua Fang¹, Mengyu Li, Jingui Hu, Yue Li, Boyang Yu, Junping Kou*,Fang Li*. Ginsenoside Rh1 mitigates mitochondrial dysfunction induced by myocardial ischemia through its novel role as a SIRT3 activator. British Journal of Pharmacology, 2025, 182(13): 3017-3035.

4. Shiyao Wan¹, ZeKun Cui¹, Lingling Wu¹, Fan Zhang, Tao Liu, Jingui Hu, Jiangwei Tian, Boyang Yu, Fuming Liu*, Junping Kou*, Fang Li*. Ginsenoside Rd promotes omentin secretion in adipose through TBK1-AMPK to improve mitochondrial biogenesis via WNT5A/Ca²⁺ pathways in heart failure. Redox Biology, 2023, 60: 102610.

5.  Qiong Lai, Fuming Liu, Wanglin Rao, Guangying Yuan, Zhaoyang Fan, Lu Zhang, Fei Fu, Junping Kou, Boyang Yu*, Fang Li*. Aminoacylase-1 plays a key role in myocardial fibrosis and the therapeutic effects of 20(S)-ginsenoside Rg3 in mouse heart failure. Acta Pharmacologica Sinica, 2022, 43: 2003-2015.